Pishko inducted into Missouri chemical engineering academy
Dr. Michael Pishko, the Stewart & Stevenson Professor II in the Department of Biomedical Engineering and director of the National Center for Therapeutics Manufacturing (NCTM) at Texas A&M University, was inducted into the University of Missouri Chemical Engineering Academy of Distinguished Alumni Oct. 10.
Pishko joined the Department of Biomedical Engineering in January 2012. Most recently, Pishko served as Charles D. Holland `53 Professor and Department Head of Chemical Engineering at Texas A&M University. In that role, he led a department of 27 tenured and tenure track faculty, 1,000 students, $13 million per year in research expenditures and $20 million in endowments. Before joining the Texas A&M faculty, he was distinguished professor and held joint appointments in the departments of chemistry and materials science and engineering at Penn State University.
In addition to his academic experience, Pishko was involved in the creation of two start-up companies in the area of diagnostic systems, has co-authored more than 100 peer-reviewed publications and proceedings and is a co-inventor of more than 22 issued U.S. patents. In 2008, he received the American Institute of Chemical Engineers (AIChE) Food, Pharmaceuticals and Bioengineering Plenary Lecture Award for his presentation “Nanoparticles for Drug Delivery and Biochemical Sensing,” detailing his research in nanoparticles drug delivery systems for chemotherapy and the development of nanosensors for mapping oxidative stress in cells.
He also serves as director of the NCTM, which is jointly operated by the university and the Texas A&M Engineering Experiment Station. This first-in-class biopharmaceutical workforce development and GMP manufacturing facility provides an interactive learning environment for trainees, students, researchers, and industrial partners.
Pishko received his B.S. and M.S. in chemical engineering from the University of Missouri, Columbia and Ph.D. in chemical engineering from the University of Texas at Austin, and postdoctoral training at the Massachusetts Institute of Technology. His research interests include microfabricated biosensors, neovascularization of implanted biomaterials and “smart” drug delivery systems.